The typical treatment for estrogen receptor positive (ER+) breast cancer involves surgery and years of hormone therapy that can come with an array of unpleasant side effects. However, a new drug ...
Holly has a degree in Medical Biochemistry from the University of Leicester. Her scientific interests include genomics, personalized medicine, and bioethics.View full profile Holly has a degree in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results